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Abstract
In HPV–related cancers, the ‘‘high-risk’’ human papillomaviruses (HPVs) are frequently found integrated into the cellular
genome. The integrated subgenomic HPV fragments express viral oncoproteins and carry an origin of DNA replication that
is capable of initiating bidirectional DNA re-replication in the presence of HPV replication proteins E1 and E2, which
ultimately leads to rearrangements within the locus of the integrated viral DNA. The current study indicates that the E1- and
E2-dependent DNA replication from the integrated HPV origin follows the ‘‘onion skin’’–type replication mode and
generates a heterogeneous population of replication intermediates. These include linear, branched, open circular, and
supercoiled plasmids, as identified by two-dimensional neutral-neutral gel-electrophoresis. We used immunofluorescence
analysis to show that the DNA repair/recombination centers are assembled at the sites of the integrated HPV replication.
These centers recruit viral and cellular replication proteins, the MRE complex, Ku70/80, ATM, Chk2, and, to some extent,
ATRIP and Chk1 (S317). In addition, the synthesis of histone cH2AX, which is a hallmark of DNA double strand breaks, is
induced, and Chk2 is activated by phosphorylation in the HPV–replicating cells. These changes suggest that the integrated
HPV replication intermediates are processed by the activated cellular DNA repair/recombination machinery, which results in
cross-chromosomal translocations as detected by metaphase FISH. We also confirmed that the replicating HPV episomes
that expressed the physiological levels of viral replication proteins could induce genomic instability in the cells with
integrated HPV. We conclude that the HPV replication origin within the host chromosome is one of the key factors that
triggers the development of HPV–associated cancers. It could be used as a starting point for the ‘‘onion skin’’–type of DNA
replication whenever the HPV plasmid exists in the same cell, which endangers the host genomic integrity during the initial
integration and after the de novo infection.
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Introduction
Papillomaviruses are small dsDNA viruses that infect the basal
cells of differentiating epithelium in variety of animals, including
humans [1]. Initial infection is followed by the transient nuclear
amplification of the HPV circular genomes via the viral pre-
replication complex (pre-RC), which is assembled by the E1 and
E2 proteins during the S-phase of the cell cycle [2–5]. E1 acts as
the replication origin recognition factor and DNA helicase [6,7].
In cooperation with E2, it licenses the papillomavirus origin within
the upstream regulatory region (URR) and initiates DNA
replication by loading the host cell replication complexes at the
origin [8–12]. Unlike cellular DNA replication, the E1- and E2-
dependent HPV DNA replication does not follow the once-per-cell
cycle initiation mode [13,14].
During their normal life cycle, HPVs must maintain their
genomes as multicopy nuclear plasmids. However, it is generally
known that the DNA of ‘‘high risk’’ human papillomaviruses (HR-
HPV), most commonly HPV16 and HPV18, are frequently
integrated into the host cell chromosome in non-invasive
squamous intraepithelial lesions (SIL) and squamous cell carcino-
mas (SCC) [15–23]. The integration of HR-HPV DNA is
considered to be an accidental but crucial step in the development
of invasive cervical cancers that drives the clonal selection of the
HPV transformed cells due to the increased expression levels of
viral oncoproteins E6 and E7 [24]. Characterization of the early
events during the integration of HPV16 before the clonal selection
has been studied thoroughly in the W12 model [23,25,26].
Limiting dilution cloning of the cells shows that viral genome
integrants arise in the presence of the HPV16 episomes and exist
under a non-competitive environment, while the expression of
integrated E6 and E7 are transcriptionally repressed by the
episome derived E2 protein [25]. Integration can occur at any
time during episome maintenance, which results in the eventual
loss of the HPV plasmids through the transient phase when the
episomal and integrated HPV DNA coexist in the same cells
[23,25]. By the time that the episome is lost and the expression of
integrated E6 and E7 oncoproteins are derepressed, transformed
cells that carry the integrated HPVs have acquired a growth
advantage for clonal selection [27–29].
We recently reported that the HR-HPV E1 and E2 proteins
that were expressed from expression vectors effectively initiate
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SiHa cell lines. This results in the amplification of the integrated
HPV origin and flanking sequences, as well as the induction of
local rearrangements, such as duplications of the cellular genome
[30]. We concluded that the DNA re-replication initiated from the
integrated HPV origin can lead to the development of chromo-
somal abnormalities, which could drive the malignant progression
and serve as a major trigger for the formation of HPV-related
cancers. Recently published data obtained with W12 cells
confirmed our findings under physiological conditions by showing
that the integration of HPV16 in these cells is accompanied by
frequent and local DNA rearrangements within the integration
locus [25]. This provides evidence that episome-derived E1 and
E2 proteins may actively interfere with the integration process at
physiological level and modify the integration locus during the S-
phase of the cell cycle by multiple initiations of DNA replication,
which generates the replication intermediates that are targets for
the DNA repair machinery. Earlier studies have shown that
genomic instability of the HPV infected cells is also increased by
the up-regulation of the expression of the viral oncogenes [31–36].
The activities of HR-HPV oncoproteins are instrumental in the
later phases of integrated HPV transformation during the clonal
selection of the cells in their progression to cancer. During the
early events of integration, however, the episome derived E2
protein effectively represses the transcription of E6 and E7
proteins [27–29,37].
In the current study, we further characterize the molecular
mechanisms of the early events during the integration of HR-HPV
and the involvement of the cellular DNA repair recombination
machinery in this process. We demonstrate that the E1- and E2-
dependent initiation of the integrated HPV replication follows the
‘‘onion skin’’-type replication mode, which leads to the formation
of different by-products, including supercoiled plasmids. We
demonstrate that these processes take place in the DNA repair/
recombination centers, which incorporate viral and cellular
replication proteins, the MRE complex, Ku70/80, ATM, Chk2,
ATRIP and Chk1 (phosphorylated at S317). All these proteins are
visualized in the repair/recombination centers in the S-phase cells
by indirect immunofluorescence assays. In addition, activation of
the ATM-Chk2 pathway is confirmed by IP-western blot analyses.
This suggests that the replication of integrated HPV activates the
DNA damage checkpoints, which results in repair of the damage
by homologous recombination (HR) and non-homologous end-
joining (NHEJ). However, not all of the damaged sites are repaired
properly in the surviving cells, as the replication of the integrated
HPV can result in a variety of rearrangements, including cross-
chromosomal translocations. In order to emphasize the role of the
replication of the integrated HPV origin in the induction of
genomic rearrangements, we also show that transfected HPV
circular genomes are not only replicating in HeLa and SiHa cells
but also mobilize the integrated HPV origin for DNA replication,
which leads to the rearrangements within the integration locus.
Based upon this, we hypothesize that the infection of immortalized
cells of SIL with homologous and heterologous HPVs might lead
to the replication of the integrated HPV origin followed by
rearrangements within the integrated locus, which is reminiscent
of the ‘‘hit-and-run’’ mechanism.
Results
Analysis of the integrated HPV replication intermediates
We have previously demonstrated that HPV replication
proteins E1 and E2, which are expressed from the heterologous
expression vectors, can induce over-amplification of the integrated
HPV origin, which leads to the chromosomal instability of the
HPV positive cancer cells [30]. In the initial studies, we used
regular one-dimensional agarose gels for the separation and
detection of the integrated HPV replication products, followed by
hybridization of the Southern blots with sequence-specific probes.
In the current study, we opted to use two-dimensional agarose gels
to further characterize the different molecular species generated at
the integrated HPV locus as a result of the replication or the action
of the cellular repair-recombination machinery. First, we enriched
the samples for the replication intermediates of the integrated
HPV by using the Hirt extraction method [38]. A considerable
part of the replicated HPV DNA appears in the low molecular
weight (LMW) fraction of the Hirt extracts (Figure 1A and 1B,
lanes 8), while there is essentially no signal for unreplicated HPV
(Figure 1A and 1B, lanes 5–7). In this experiment, HeLa cells (1A)
and SiHa cells (1B) were transfected either with carrier DNA (lanes
1 and 5), HPV18 E1 expression vector alone (lanes 2 and 6),
HPV18 E2 expression vector alone (lanes 3 and 7), or with HPV18
E1 and E2 expression vectors together (lanes 4 and 8). Low
molecular weight (LMW) and high molecular weight (HMW)
DNA fractions were separated on one-dimensional agarose gel and
analyzed by Southern blot with HPV18 (1A) or HPV16 (1B)
URR-specific probes. Quantification showed that over 50% of the
replication signal of integrated HPV (Figure 1A and 1B, compare
lanes 4 and 8) can be found in the Hirt LMW extract compared to
5% of the unreplicated DNA of the integrated virus (Figure 1A
and 1B, compare lanes 1–3 with 5–7).
In order to identify the topology of the replication intermediates
and replication products, the Hirt LMW DNA from the E1/E2-
transfected HeLa cells was further fractionated by conventional
CsCl density gradient centrifugation in the presence of ethidium
bromide. This procedure separates the supercoiled and non-
supercoiled DNA molecules based upon the differences in buoyant
density. Both fractions were separately subjected to two-dimen-
sional neutral-neutral gel-electrophoresis, and the HPV18 repli-
cation products were examined by hybridization of the Southern
blots with an HPV18 genome probe. In the first dimension of 2D
gels, using low voltage and low agarose concentration, the DNA
Author Summary
High-risk human papillomavirus infection can cause
several types of cancers. During the normal virus life cycle,
these viruses maintain their genomes as multicopy nuclear
plasmids in infected cells. However, in cancer cells, the viral
plasmids are lost, which leaves one of the HPV genomes to
be integrated into the genome of the host cell. We suggest
that the viral integration and the coexistence of episomal
and integrated HPV genomes in the same cell play key
roles in early events that lead to the formation of HPV–
dependent cancer cells. We show that HPV replication
proteins expressed at the physiological level from the viral
extrachromosomal genome are capable of replicating
episomal and integrated HPV simultaneously. Unsched-
uled replication of the integrated HPV induces a variety of
changes in the host genome, such as excision, repair,
recombination, and amplification, which also involve the
flanking cellular DNA. As a result, genomic modifications
occur, which could have a role in reprogramming the HPV–
infected cells that leads to the development of cancer. We
believe that the mechanism described in this study may
reflect the underlying processes that take place in the
genome of the HPV–infected cells and may also play a role
in the formation of other types of cancers.
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In the second dimension, the molecules are separated based upon
their topology due to increased voltage, higher agarose concen-
tration, the presence of EtBr, and the low temperature. As a result,
the supercoiled (sc), open circular (oc), and branched molecules
have an altered mobility when compared with the linear molecules
with the same mass, which appear as distinct arcs on 2D gels. The
theoretical scheme for this type of analysis of the replication
products is presented in Figure 1C. Analysis of the fraction
containing non-supercoiled DNA molecules from the CsCl
gradient (Figure 1D) shows three arcs of the replicated molecules,
which were arcs of the linear fragments, branched molecules, and
open circular plasmids of different sizes. Linear DNA fragments
and branched molecules can be generated by displacement
synthesis, replication fork collisions, and by mechanical shearing
of the DNA during cell lysis, even if the lysates are handled gently.
The appearance of the arc of open circular molecules (Figure 1D)
suggests that active processing of the replication products is
ongoing in these cells and that this leads to the excision of the HPV
DNA from the cellular genome. A fraction of the supercoiled DNA
(scDNA) molecules from the CsCl gradient was analyzed in a
similar manner on the 2D gel (Figure 1E). No linear HPV
fragments in this fraction were detected, but the arc of the
covalently closed circular plasmids of heterogeneous size is clearly
visible. The local shift in the migration of the arc of the supercoiled
molecules (black arrowhead, Figure 1E) is caused by the large
quantity of mtDNA that serves as an additional internal control for
the arc of circular molecules [39]. Since the arc of scDNA
continues beyond that shift further into the higher molecular
weight region, we can conclude that covalently closed circular
molecules larger than 16 kb are generated as a result of the
replication of the integrated HPV. Several stronger signals can be
detected on the arc of supercoiled plasmids, which indicates either
that certain excised HPV molecules are replicating more efficiently
than the others, or that specific replication products are
accumulating as a result of the stalling of replication forks.
Therefore, we conclude that excision and active processing of the
replicated HPV sequences are ongoing in the cells where E1- and
Figure 1. DNA replication initiated from the integrated HPV origin generates various low-molecular-weight DNA products. High-
molecular-weight (HMW) DNA and low-molecular-weight (LMW) DNA were fractionated and purified by Hirt lysis 24 hrs post-transfection from HeLa
cells (A) and from SiHa cells (B) that were both transfected as follows: mock-transfection (lanes 1 and 5); 5 mg of HPV18 E1 expression plasmid (lanes 2
and 6); 2 mg of E2 expression plasmid (lanes 3 and 7); 5 mg of HPV18 E1 and 2 mg of E2 expression plasmids (lanes 4 and 8). A 3 mg portion of HMW
DNA and three times the respective amount of LMW DNA were digested with HindIII (A) or Acc65I/BshTI (B) and separated on a one-dimensional gel.
The integrated HPV URR-specific signals were detected by Southern blot analysis. (C) Schematic presentation of the migration of dsDNA linear,
supercoiled, and open circle molecules on 2D neutral-neutral gels. (D, E) 5 mg of HPV18 E1 and 2 mg of E2 expression plasmids were transfected into
HeLa cells and LMW DNA was purified by Hirt lysis 48 hrs post-transfection. Extracted DNA was digested with DpnI and fractionated by the CsCl-
ethidium bromide density gradient. The fraction of linear fragments (lin) and open circular molecules (oc) (D) and the fraction of supercoiled circular
plasmids (sc) (E) were separated on a 2D gel, transferred to a nylon filter, and probed with the HPV18 genomic fragment (from nt 3917 to1575).
Numbers shown on the axes represent the markers of linear (lin) and supercoiled circular (sc) DNA forms. Black arrowhead indicates the shift that was
caused by mtDNA. (F) Schematic presentation of HPV16 integration locus within chromosome 13 in SiHa cells, where the cleavage sites of Acc65I,
Eco91I, BshTI, and BcuI as well as their distances from HPV origin are presented. (G) Schematic presentation of the migration of replication forks and
replication puffs on 2D neutral-neutral gels. (H,I) SiHa cells were co-transfected with 5 mg of HPV18 E1 and 2 mg of E2 expression plasmids. LMW DNA
was extracted 24 hrs post-transfection and digested with Acc65I-BshTI (H) and Eco91I-BcuI (I). Respective HPV16 genome fragments were used as
probes on 2D Southern blots. (J) SiHa cells were co-transfected with 1 mg of HPV18 E1 and 2 mg of E2 expression plasmids. Extracted LMW DNA was
digested with Eco91I-BcuI and analyzed by 2D Southern blots.
doi:10.1371/journal.ppat.1000397.g001
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heterogeneous set of the supercoiled and relaxed plasmid circles
that was detected in such cells could comprise actively replicating
molecules, since they do contain the HPV18 replication origin.
The detection of the open circles and supercoiled molecules also
suggests that the cellular repair and recombination machinery is
actively involved in this process.
The bidirectional nature of DNA replication that is initiated from
the integrated HPV origin has been previously shown by us and was
referred to as the ‘‘onion skin’’-type of replication mode [30]. To
confirm this, we analyzed the replication intermediates of the
integrated HPV16 in SiHa cells carrying a single integration site of
HPV16 on chromosome 13 (Figure 1F). SiHa cells were co-
transfected with HPV16 E1 and E2 expression vectors and the
LMWDNAwasextracted24 hpost-transfectionbyHirtlysis.DNA
samples were digested with Acc65I-BshTI or Eco91I-BcuI,
separated by neutral-neutral 2D gel-electrophoresis, blotted, and
hybridized with the corresponding HPV16 genome fragment
(Figure 1H, 1I, and 1J, respectively). The scheme in Figure 1G
demonstrates the idealized autoradiographic pattern of typical
replication intermediates of the bidirectional DNA replication,
which include the arc of replication forks and the arc of bubbles/
puffs. The specific pattern depends on the location of the origin
within the restriction fragment. In the blot of Acc65I/BshTI
digested DNA (Figure 1H), the hallmarks of the bidirectional
replication can be clearly detected. The full-size arc of the
replication forks from 1 N to 2 N size of the cleaved fragment
indicates that the HPV16 origin is actively used for initiation of
DNA synthesis. In addition, the arc of linear DNA fragments along
with the larger structures, which presumably represent various
branched onion skin-type replication intermediates, can be
detected. The symmetrical cleavage of replication products with
Eco91I/BcuI (Figure 1I and 1J) confirms that the initiation of
replication takes place at the HPV16 replication origin, because the
tip of the arc representing the replication forks could be identified in
addition to the linear fragments, branched DNA structures, and
bubbles. Interestingly, the detected bubble arc was more upright
than is typically seen in case of cellular eukaryotic origins [40],
although we have previously proven that replication starts from the
HPV origin and extends bidirectionally [30]. The only explanation
for the discrepancy is that the new replication forks from the
integrated HPV origin start before the previous ones have been
extended outside of the restriction fragment, and, as a result, DNA
fragments with multiple bubbles (DNA puffs) are generated. Clear,
upright arcs that could represent the replication puffs were even
detected at lower E1 levels (Figure 1J). Therefore, we conclude that
the true ‘‘onion skin’’ type molecules were detected as replication
bubbles/puffs. A similar upright arc of bubbles has been previously
shown in the case of BPV-1 DNA replication, which also follows the
‘‘onion skin’’-type replication mode [41].
DNA replication of the integrated HPV takes place at
specific nuclear foci
DNA replication of eukaryotic cells occurs within defined sites
throughout the nucleus, as identified by co-localization of
replication factors and nascent bromodeoxyuridine (BrdU) labeled
DNA into distinct foci [42–44]. It has also been demonstrated that
papillomaviruses, which are similar to many other DNA viruses,
replicate their genome at specific nuclear extrachromosomal foci in
infected cells [45]. To identify the replication sites of integrated
HPV, we transfected SiHa cells with HPV16 E1 and E2 expression
vectors and HeLa cells with HPV18 E1 and E2 expression vectors.
Twentyhourspost-transfection,thecellswerelabeled with BrdUfor
2 hours, followed by double immunostaining for BrdU and HA-
tagged HPV E1 protein. The results show that BrdU was
incorporated throughout the nucleus in the cells without the E1
protein. However, in cells that were positive for E1 and E2, the
BrdU signal was mostly co-localized within the E1 foci (Figure 2A).
In such cases, we always identified 2 foci in the SiHa cells and 3 foci
in the HeLa cells, although they were heterogeneous in size and
there was a tendency for satellite foci later in the time course
(Figure 2A). These foci likely represent the integratedHPV sites that
are capable of active replication in these cell lines. The SiHa cells
contain two chromosome 13’s that carry the single HPV16
integration site [46–48], which suggests that both copies of the
HPV16 are active for replication. In HeLa cells, at least five HPV18
integration sites have been mapped. Three of them are located on
normal chromosomes 8 at 8q24 and two on derivative chromo-
somes, which have been shown to contain material from 8q24 [49].
We conclude that there are three replication competent loci of the
HPV18 in HeLa cells. BrdU incorporation within the E1 foci
indicates that the replication of the integrated HPV origin can be
visualized by E1 immunofluorescence analysis and that such
compartmentalization of E1 to these foci occurs only during S-
phase of the cell cycle. To confirm that the visualized foci represent
the HPV replication centers, the immunostaining for E1 was
combined with FISH analysis for the integrated HPV-specific DNA
(Figure 2B). The amplified DNA of HPV16 (in SiHa cells) and
HPV18 (in HeLa cells) are detected at the same foci as the E1
protein (Figure 2B). These data again suggest that the E1 foci are
bona fide amplification sites of the integrated HPV.
To further elaborate on the potential functionality of these
detected foci, we performed co-immunostaining for E1 and E2,
PCNA, the RPA p70 subunit or the polymerase/a-primase (pola)
in HeLa cells that were transfected with the HPV18 E1 and E2
expression vectors (Figure 3). We detected the same pattern of co-
localization of E1 and the other replication proteins as earlier,
which once more demonstrates that these foci are active DNA
replication initiation centers of the integrated HPV. This is
supported by the fact that the E2 protein is not required for the
unwinding or the helicase activity of E1 during DNA replication
elongation and, likewise, the fact that pola is not required for DNA
repair processes. The percentage of the E1/E2 positive cells with
the characteristic pattern of viral DNA replication was estimated
to be 5% to 10%, which represents a fairly large fraction of cells in
S-phase within the transfected cell population. In the case of the
HPV18 replication proteins, we also detected some satellite foci in
addition to the main ones in both HeLa cells (Figure 3) and SiHa
cells (data not shown). The relative amount of the cells with
satellite foci increased over time from 26% at 12 h post-
transfection to 74% at 48 h, as evaluated by two independent
experiments in the HeLa cells. Co-localization of HPV18 E2,
PCNA, the RPA p70 subunit, and pola with HPV E1 indicates
that these additional foci may represent the extrachromosomal
fraction of the replicating, HPV origin containing, plasmids, which
originated from the integrated HPV locus due to its over-
amplification. These molecules were clearly detected by the two-
dimensional gel-electrophoresis analyses (Figure 1E).
Promyelocytic leukemia (PML) nuclear bodies are nuclear
structures that serve the role of storage site for numerous proteins
that are associated with almost every nuclear function, including
transcription, DNA repair, viral defense, stress, cell cycle
regulation, proteolysis, and apoptosis [50]. It has been suggested
that the replication of the HPV genomes might take place in the
PML bodies as well [45]. To investigate the location of the
integrated HPV replication in relation to the PML bodies, we
performed co-immunofluorescence analyses for the HPV18 E1
and Daxx proteins (Figure 3). The Daxx protein has been shown
Replication of Integrated HPV
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shows that there is no co-localization between the Daxx and
HPV18 E1 foci, which suggests, first, that replication of the
integrated HPV does not take place in PML bodies and, second,
that the E1 foci are not the artificial accumulation centers for the
replication proteins due to the overexpression of E1 and E2.
Double immunostaining was also performed on mock-trans-
fected cells and on cells transfected with E1 expression plasmids
alone. However, we failed to detect any such foci in these SiHa or
HeLa cells. Taken together, these results demonstrate that the
replication of integrated HPV takes place at specific foci in the cell
nucleus, which can be visualized by indirect immunofluorescence
analysis or by FISH.
Replication centers of the integrated HPV recruit Mre11-
Nbs1-Rad50 complex and Ku70/80 heterodimer
Our data show that the replication of integrated HPV gives rise
to the linear, branched, ‘‘onion skin’’-type replication intermedi-
ates, as well as open circular and supercoiled circular DNA
molecules (Figure 1) in the nuclear replication centers (Figure 2
and Figure 3). Clearly, the generation of such irregularities in the
cellular genome should trigger the cellular responses to repair it.
We assume that DNA double-strand brakes (DSBs) are generated
at some stage of the HPV ‘‘onion skin’’ type of replication. There
are two major mechanisms for the repair of DNA DSBs, which are
homologous recombination repair (HR) and non-homologous end
joining (NHEJ) [52–54]. Primary sensors that detect DNA DSBs
are the Mre11-Nbs1-Rad50 (MRN) complex, in the case of HR,
and the Ku70/80 heterodimer, in the case of NHEJ. To
investigate the potential linkage of cellular DNA repair mecha-
nisms to the integrated HPV DNA replication, we assessed the
localization of the MRN complex and Ku70/80 heterodimer in
relation to the E1 protein in HeLa cells that were transfected with
the HPV18 E1 and E2 expression vectors. Indirect immunostain-
ing demonstrates that all components of the MRN complex as well
as the Ku70/80 heterodimer are co-localized within the foci of the
Figure 2. DNA replication of the integrated HPV takes place at specific nuclear foci. HeLa and SiHa cells were co-transfected with 5 mgo f
HPV18 E1 and 2 mg of E2 expression plasmids. Cells were analyzed 20 hrs post-transfection. (A) Co-immunostaining of E1 (Alexa Fluor 568, first
column) and BrdU (FITC, second column). Cells were pulse-labeled with BrdU for 2 hrs prior to IF analysis. In the third column, the localizations of E1
and BrdU in the same cells are presented as a merged image. (B) Combined immunofluorescence and FISH analysis to detect the integrated HPV DNA
(Alexa Fluor 488, first column) and the HPV E1 protein (Alexa Fluor 568, second column) in SiHa and HeLa cells. Localizations of the E1 and the
integrated HPV DNA are also presented in the third column as a merged image. DNA was counterstained with DAPI (fourth column).
doi:10.1371/journal.ppat.1000397.g002
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sites (Figure 4). These data suggest that the cell senses the
irregularities in the genome that are generated by the viral
replication proteins and attempts to resolve the over-amplification
of the HPV region by the recruitment of the MRN complexes and
the Ku70/80 heterodimers. We conclude that both pathways of
DNA repair/recombination are activated at the site of the
integrated HPV DNA replication. We believe that most of the
irregularities are fixed, but, in some cases, these repairs can lead to
rearrangements that involve genomic sequences [30], which lays
the ground for genomic instability.
Repair of the amplified HPV18 integration locus is
coordinated by the ATM and ATR signaling pathways
Eukaryotic cells respond to DNA damage with a rapid activation
of signaling cascades that are initiated by the ataxia telangiectasia
mutated (ATM) kinase and the ATM and Rad3-related (ATR)
kinase. Response to the DSBs, which can be caused by ionizing
radiation or radiomimetic drugs, occurs primarily through the
ATM-Chk2 signaling pathway. In response to replication fork
stalling and other forms of DNA damage that are caused by
ultraviolet light, cells activate replication checkpoints, where the
central players are the ATR kinase, ATRIP (ATR-interacting
Figure 3. Cellular replication factors colocalize with the HPV 18 E1 in HeLa cells. Cells were transfected and analyzed as described
previously. Co-immunostaining of HPV18 E1 (Alexa Fluor 568, second column) together with the following proteins are shown: HPV18 E2, PCNA, RPA,
polymerase a/primase, and Daxx (Alexa Fluor 488, first column). Merged images are presented in the third column and DAPI stained nuclei in the
fourth column.
doi:10.1371/journal.ppat.1000397.g003
Replication of Integrated HPV
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which pathways are activated and recruited to the foci due to the
replication of integrated HPV18, we performed co-immunostaining
analyses forthe HPV18 E1proteinalong withATM, Chk2, ATRIP,
or Chk1 proteins in HeLa cells that were transfected with the
HPV18 E1 and E2 expression vectors (Figure 5). The results show
clear co-localization of ATM and Chk2 at the HPV replication foci,
which indicates that a response to DSBs is generated during the
HPV replication process. ATRIP also localizes within the HPV
replication foci, which demonstrates the presence of RPA-coated
ssDNA. In the case of the Chk1 protein, there was only poor co-
localization of the Chk1 and E1 proteins when an antibody against
phosphorylated Chk1 (S317) was used (Figure 5). There was no co-
localization with the E1 protein when the primary antibody against
the unphosphorylated form of Chk1 was used (data not shown).
Activation of the ATM-Chk2 DNA damage-signaling
pathway is induced as a result of the integrated HPV
replication
The data presented above clearly indicate that the DNA
double-strand break repair machinery is recruited to the
replication foci of integrated HPV. We further studied the
activation status of the DNA DSB repair systems. HeLa cells
were transfected with the HPV18 E1 and E2 expression vectors
(Figure 6A–6C, lane 1), the HPV18 E1 expression vector
(Figure 6A–6C, lane 2), the HPV18 E2 expression vector
(Figure 6A–6C, lane 3), or carrier DNA (Figure 6A–6C, lane 4).
Untransfected HeLa cells (Figure 6A–6C, lane 5) and HeLa cells
that were treated for 1 hour with etoposide (Figure 6A–6C, lane 6)
were used as controls. The transfected cells were first analyzed for
E1 and E2 expression (Figure 6A, panels a and b, respectively)
24 hrs post-transfection using normalized western blot analysis.
DNA double-strand break repair originating from diverse causes
in eukaryotic cells are accompanied by the upregulation of
phosphorylated cH2AX protein (at serine 139) at the sites of DSBs
in chromosomal DNA. This phosphorylated form of cH2AX is
rapidly formed in cells that are treated with ionizing radiation (IR)
and also during V(D)J and class-switch recombination and
apoptosis. Since cH2AX appears within minutes after IR, the
production of the phosphorylated form of cH2AX is considered to
be a sensitive and selective signal for the existence of DNA double-
strand breaks. Indeed, treatment of the HeLa cells with etoposide,
Figure 4. Replication centers of the integrated HPV recruit Mre11-Nbs1-Rad50 complex and Ku70/80 heterodimer. HeLa cells were
transfected and analyzed as described previously. Co-immunostaining of HPV18 E1 (Alexa Fluor 568, second column) and the following proteins are
presented: Mre11, Nbs1, Rad50, and Ku70/80 proteins (Alexa Fluor 488, first column). The localizations of the E1 and the respective DNA repair
proteins are also shown in the third column as a merged image and DAPI stained nuclei are presented in the fourth column.
doi:10.1371/journal.ppat.1000397.g004
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of the phosphorylated form of the cH2AX in these cells (Figure 6A,
panel c, lane 6). In addition, we detected a considerable increase of
the phosphorylated form of cH2AX when the E1 and E2 proteins
were co-transfected into HeLa cells (Figure 6A, panel c, lane 1).
This indicates that the cellular response to the DNA DSBs that are
generated by the replication of the integrated HPV DNA is clearly
activated. We further analyzed the activation status of Chk2 at the
same time point by using IP-western blot analysis with
phosphorylation specific antibodies (Figure 6B). HeLa cells, which
were transfected in a manner similar to the procedure that was
used in Figure 6A, were lysed and subjected to immunoprecip-
itation with the anti-Chk2 antibody. The immunoprecipitated
protein samples were further analyzed with phosphorylation-
specific antibodies targeted against the Chk2 phosphopeptides that
contain Thr68 or Ser19. These sites are part of a cluster of S/TQ
phosphorylation sites that are recognized by PIKKs (PI3 kinase-
like kinases) such as ATM and ATR [55]. It is known that all S/
TQ sites in the N terminus of Chk2 are individually sufficient to
activate the protein [56]. As expected, strong phosphorylation of
Chk2 at Thr68 and Ser19 were detected in the case of etoposide–
treated cells (Figure 6B, lane 6). In addition, a modest activation of
Chk2 can be observed in the cells that were transfected with E1
expression vector alone (Figure 6B, lane 2). However, this effect
was considerably enhanced when E1 and E2-dependent replica-
tion was initiated in HeLa cells (Figure 6B, lane 1). Interestingly,
Ser19 is phosphorylated exclusively in response to DSBs in an
ATM- and Nbs1-dependent but ATR-independent manner [57].
We conclude that E1 protein expression can, to some extent,
activate the Chk2 kinase, which is further activated by the
replication of the integrated HPV. Similar IP-western blot analysis
of Chk1 activation in these cells showed a very weak elevation of
the phosphorylation at Ser317 in the E1-transfected cells, which
was not enhanced by the replication of integrated HPV and, by no
means, was comparable to the effect of the etoposide-treatment of
the cells (Figure 6C, compare lanes 1 and 2 to lane 6). We can only
speculate why Chk1 and Chk2 are slightly activated in response
the E1 expression. It could be either direct interactions with the
components of the DNA repair pathways or an unspecific binding
and unwinding of the cellular DNA.
Finally, we examined the phosphorylation status of Chk2 kinase
at Ser19 in HeLa cells, which simultaneously contain the
Figure 5. Repair of the amplified HPV18 integration locus is coordinated by the ATM and ATR signaling pathways. HeLa cells were
transfected and analyzed as described previously. Co-immunostaining of HPV18 E1 (Alexa Fluor 568, second column) and the following proteins are
shown at the figure: ATM, Chk2, ATRIP, and Chk1 (S317) (Alexa Fluor 488, first column). Merged images are shown in the third column and DAPI
stained nuclei in the fourth column.
doi:10.1371/journal.ppat.1000397.g005
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E2 proteins at physiological levels. HeLa cells were co-transfected
with the circular HPV18 genome and the pBabePuro plasmid,
untransfected cells were removed with puromycin treatment, and
Chk2 phosphorylation was analyzed at a 72 h time point by IP/
western blot with the Ser19 phosphorylation-specific antibody
(Figure 6D, lane 1). Mock-transfection with the carrier plasmid
(Figure 6D, lane 2) as well as untransfected HeLa cells (Figure 6D,
lane 3) were used to determine the background level of
phosphorylation. Etoposide-treated HeLa cells were used as a
positive control (Figure 6D, lane 4). Despite the slightly higher
levels of phosphorylated Chk2 in the mock-transfected cells, the
increased activation of Chk2 is clearly observed in HeLa cells that
were transfected with the HPV18 genome. This can be caused
either by the replication of the HPV plasmid or by the integrated
HPV origin, and this refers to the active processing of DSBs, which
might lead to host chromosomal instability.
Re-replication of the integrated HPV can induce the
instability of chromosome structure as detected by
metaphase FISH analysis
Cervical carcinogenesis is associated with the acquisition of
structural and numerical chromosomal abnormalities after the
integration of HPV into the host cell genome [26,34]. One
potential reason is believed to be the increased levels of the HPV
E6 and E7 proteins, which is caused by the disruption of E2
transcriptional repressor expression [23,31]. However, there is also
an alternative mechanism that might cause the chromosomal
rearrangements, which involves the over-amplification of the
integrated HPV combined with the cellular attempt to fix the
resulting DSBs by HR and NHEJ. We previously demonstrated,
by restriction analysis, that the local region of the integrated HPV
DNA changes dramatically upon in situ re-replication of the
integrated HPV [30]. In this previous work, SiHa cells were
transfected with the HPV16 E1 and E2 expression plasmids, the
resulting transfected cells were single cell subcloned, and changes
in the HPV16 restriction pattern, which could represent either an
internal rearrangement or a reintegration at a novel site, were
examined. The subclones with altered restriction pattern was
further investigated in the current study by metaphase FISH in
order to detect possible chromosome alterations that are associated
with the replication of the integrated HPV. We used the tyramide-
enhanced FISH method for the detection of HPV16 sequence in
combination with a subtelomeric probe specific for chromosome
13 (CytoCell). The results demonstrate that there are two
chromosome 13’s within the SiHa cells and that both carry the
HPV sequence (Figure 7A, one nucleus in interphase, and two
metaphase chromosome spreads are presented). The HPV16
DNA was labeled with Alexa Fluor 488 and was visible as green
dots, while the chromosome 13 subtelomeric regions were labeled
with Texas Red and were visible as red dots. More importantly,
the de novo cross-chromosomal translocation of the HPV16 genome
along with the entire q-arm of chromosome 13 could be detected
in one of the subclones, where the DNA replication of integrated
HPV had been initiated (Figure 7B, one nucleus in interphase and
two metaphase chromosome spreads are presented). As a result,
there is third 13q arm in the haploid genome of this subclone.
Immunofluorescence analyses of the subclone showed three
replication foci as compared to the two foci that we exclusively
detected in SiHa cells (data not shown). Over one hundred
metaphase spreads of SiHa cells were analyzed and no type of
heterogenity in our cell population was detected with regard to the
HPV integration site.
Figure 6. Activation of the ATM-Chk2 signaling pathway. (A–C)
HeLa cells were transfected as follows: 5 mg of HPV18 E1 and 2 mgo f
HPV18 E2 expression plasmids (lane 1); 5 mg of HPV18 E1 expression
plasmid (lane 2); 2 mg of E2 expression plasmid (lane 3); and a mock-
transfection (lane 4). In every transfection, the amount of plasmid was
adjusted to 10 mg with a carrier plasmid (pauxoMCF). Non-transfected
HeLa cells are presented in lane 5 and HeLa cells that were treated 1 h
with etoposide (50 mM) prior to the analysis in lane 6. Western blot
analyses were performed at a 24 hrs time point to detect HPV18 E1 (A,
panel a),HPV18 E2 (A,panel b), gamma histone H2AX (phosphorylated at
S139) (A, panel c), and b-actin (A, panel d). Western blot analyses of Chk2
phosphorylated at Thr68 and Ser19 were performed after the immuno-
precipitation with the anti-Chk2 antibody (B, panels a, b, c). Chk1
phosphorylated at Ser317 was detected from extracts that were
immunoprecipitated with the anti-Chk1 antibody (C, panels a, b). (D)
HeLa cells were transfected either with 2 mg of circular HPV18 genome,
2 mg of pBabePuro and 6 mg of carrier plasmid (lane 1), or with 2 mgo f
pBabePuro and 8 mg of carrier plasmid (lane 2). Untransfected cells were
removed with puromycin treatment (2 mg/ml) 24–48 h posttransfection.
Western blot analyses with anti-Chk2 (panel a) and anti-Chk2-Ser19
(panel b) antibodies were performed after the immunoprecipitation with
the anti-Chk2 antibody at a 72 h time point. Untreated HeLa cells are
shown in lane 3 and etoposide-treated HeLa cells in lane 4.
doi:10.1371/journal.ppat.1000397.g006
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genome in HPV positive cancer cell lines; induction of the
genomic instability in SiHa cells harboring the integrated
HPV16
The data presented here and previously by us [30] raise an
important question about the stability of the integrated HPV loci
in the presence of viral replication proteins at physiologically
relevant expression levels. Recent findings from the W12 cell line
indicate that local rearrangements occur frequently and shortly
after natural HPV16 integration, during the phase when episomal
and integrated viral genomes are present in the same cell [25].
Similar translocations of the viral-host DNA have also been
detected in several cell lines that were derived from invasive genital
carcinomas [33,58,59]. We decided to address this question by
applying the protocols used in human keratinocytes [60,61] to the
HPV-positive cancer cell lines— HeLa and SiHa. The HPV16
and HPV18 genomes were excised from the vector backbone,
purified and re-circularized at low concentrations. The circular
viral genomes were then transfected into HeLa and SiHa cells
along with the linearized plasmid that carries the selection marker
for G418.
At first, the efficiency of the transient replication of the viral
genomes was evaluated in these cell lines. The low-molecular-
weight DNA was extracted 24 h and 48 h posttransfection and
used in Southern blot analysis with HPV16- or HPV18-specific
probes. A clear DpnI-resistant replication signal from the HPV16
and -18 plasmids was detected in both cell lines (HPV16 in HeLa:
Figure 8A, lanes 1–2; HPV18 in HeLa: Figure 8B, lanes 1–2;
HPV16 in SiHa: Figure 8C, lanes 3–4; HPV18 in SiHa: Figure 8D,
lanes 3–4). This demonstrated that circular HPV genomes are
capable of transient replication in cells that carry the integrated
HPV subgenomic fragments. With that knowledge, we subse-
quently studied the stability of the integrated HPV locus in the
Figure 7. Re-replication of the integrated HPV induces the instability of chromosome structure. SiHa cells were transfected with 10 mgo f
HPV18 E1 and 5 mg of E2 expression plasmids. Single cell subcloning was performed 72 h after transfection [30]. SiHa cells and the subclones with
novel restriction patterns were analyzed by FISH. (A) FISH analysis of the interphase nuclei (left panel) and metaphase chromosome spreads (the
middle and the right panels) of SiHa cells. (B) Interphase FISH (left panel) and metaphase FISH (the middle and the right panels) analyses of the
subclone with cross-chromosomal translocation. The integrated HPV16 is visible as green (Alexa Fluor 488), and the subtelomeric region of the
chromosome 13 is visible as red (Texas Red). The translocation of 13q is indicated with the white arrowhead.
doi:10.1371/journal.ppat.1000397.g007
Replication of Integrated HPV
PLoS Pathogens | www.plospathogens.org 10 April 2009 | Volume 5 | Issue 4 | e1000397presence of the replicating HPV episome. The HPV16- and
HPV18-transfected SiHa cells were grown under the G418
selection to eliminate any untransfected cells. The total DNA
was extracted five weeks post-transfection, and the HPV16-specific
restriction patterns were analyzed by Southern blotting. Com-
pared to the restriction pattern in untreated SiHa cells (Figure 8E,
lanes 1–3), the results revealed a few unique, but faint bands in the
HPV16-transfected cells (Figure 8E, lanes 4–6) and an unchanged
restriction pattern in the HPV18-transfected cells (Figure 8E, lanes
13–15). These observations could be explained either by the low
abundance of the cells that had altered host genomic content or by
the presence of the episomal HPV16 plasmid in the HPV16-
transfected cells with an intact host genome. To clarify this issue,
the transfected cells were further subcloned. Six of the HPV16-
and six of the HPV18-transfected subclones were analyzed as
before by Southern blotting with HPV16-specific probe. Two
HPV16-transfected subclones with unique restriction fragments
were identified, and they represent either integration of the
transfected HPV16 plasmid into the host genome or the excision
and re-integration of the initially integrated HPV16 (Figure 8E,
lanes 7–12). More importantly, unique HPV16-specific fragments
were also identified in one of the HPV18-transfected subclones
(Figure 8E, lane 16–18). In this case, it could only indicate the re-
arranged loci of the integrated HPV16 due to the presence of an
episomal HPV18. Parallel Southern blot analysis with an HPV18-
specific probe revealed that, similarly to HPV16, the HPV18
Figure 8. The HPV genome induces genomic instability in cells harboring the integrated HPV. Southern blot analyses of the HeLa (A, B)
and SiHa cells (C, D) co-transfected with 1 mg of HPV16 genome and 1 mg of linearized pEGFPN-1 (A, C) or with 1 mg of HPV18 genome and 1 mgo f
linearized pEGFPN-1 (B, D). Low-molecular-weight DNA was extracted 24 h and 48 h after transfection and digested with restriction enzymes, as
indicated in the figure. HPV plasmids were detected with a
32P-labeled HPV16 or HPV18 genome probe, respectively. (E, F) The restriction analyses of
untreated SiHa cells (E, lanes 1–3), HPV16-transfected SiHa cells five weeks post-transfection (E, lanes 4–6), HPV18-transfected SiHa cells five weeks
post-transfection (E, lanes 13–15; F, lanes 1–3), as well as the subclones of the HPV16-transfected SiHa cells (E, lanes 7–12) and HPV18-transfected
SiHa cells (E, lanes 16–18; F, lanes 4–6). Digested total DNA was analyzed by Southern blotting, where the HPV16 (E) or HPV18 (F) genomes were used
as probes. Restriction enzymes are indicated in the figure.
doi:10.1371/journal.ppat.1000397.g008
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genome (Figure 8F). This has been confirmed with 2D gels (data
not shown).
In conclusion, these data suggest that the presence of the HPV
plasmid in cells that have an integrated HPV origin can change
the host genomic content.
Discussion
Once per cell cycle DNA replication in eukaryotic cells is
accomplished by temporal separation of the assembly of pre-
replication complex (pre-RC) and the actual initiation of DNA
synthesis [62,63]. However, the formation of HPV pre-RC that is
orchestrated by the viral E1 and E2 proteins can occur
simultaneously with the viral DNA synthesis, which allows the
HPV origin to be licensed for multiple initiations of DNA
replication during a single cell cycle [5]. These multiple initiations
can effectively complete the DNA replication of the small HPV
plasmid at physiological conditions and guarantee its extrachro-
mosomal amplification and maintenance. At the same time, HR-
HPV DNA can integrate into the host genome at any time during
its episomal maintenance [25], which generates the combination
of two HPV origin entities in the same cell – integrated and
episomal. Our recent work showed that the integrated HR-HPV
origins are effectively mobilized for replication by E1 and E2,
which can lead to the generation of irregularity in the genomic
DNA [30]. Based upon our previous demonstrations, these
genomic irregularities are partially resolved in the clonally derived
cells, where we found the rearranged tandem repeats of the HPV-
host DNA junctions [30]. It should be emphasized that similar
rearrangements at the loci of integrated HPV are described in
W12 cells during the integration of episomal HPV16 [25] and in
SiHa cell lines that are transfected with the HPV16 and HPV18
genomes (Figure 8). These data indicate that the mobilization of
an integrated HPV origin for DNA replication and the subsequent
actions of the cellular DNA repair/recombination machinery
occur during episomal HPV replication at a physiological level of
the replication proteins.
Current analysis of the replication intermediates in SiHa cells
show that integrated HPV follows the ‘‘onion skin’’-type of DNA
replication mode. In addition to linear and branched DNA
molecules, heterogeneous populations of supercoiled and open
circular plasmids were formed. These HPV-origin containing
plasmids are most likely the templates for the E1 and E2-driven
DNA replication and might be, therefore, one of the mechanisms
for gene amplification. Similar chromosomal excision and
formation of a heterogeneous pool of circular molecules has also
been detected earlier in case of the DNA re-replication of
integrated SV40 in the presence of large T antigen [64–66].
The structures of DNA breaks that are generated by HPV DNA
re-replication should not differ from other types of double strand
breaks (DSB), and they should be recognized in eukaryotic cells by
either non-homologous end-joining (NHEJ) or homologous
recombination (HR). We demonstrated by indirect immunofluo-
rescence that the initiation factors of both NHEJ and HR are
localized at the integrated HPV replication centers, which suggests
that DSBs are generated by the re-replication of the HPV locus. It
is possible that HR, which is the primary DNA repair mechanism
in the S-phase, might get saturated by the abundant generation of
DSBs during the integrated HPV replication, which would lead to
some of the DSBs being repaired by NHEJ. Although the NHEJ
machinery plays a significant role in maintaining genome stability
and suppressing tumorigenesis [67–69], it is also responsible for
the vast majority of tumorigenic chromosomal translocations.
Even the ‘‘correct’’ re-joining of broken ends by NHEJ often
results in mutations at the junctions [70]. Therefore, NHEJ may
primarily contribute to the development of genetic instability that
is found in HPV-associated cancers.
Forced assembly of the cellular pre-RC in the S-phase leads to
the re-replication of the cellular DNA and the activation of various
checkpoint pathways [71–73]. In mammalian cells, the ATR-
mediated S-phase checkpoint is immediately activated after
accumulation of the RPA-coated ssDNA and before the
appearance of DSBs to prevent further DNA re-replication
[71,74]. However, our data indicate that ATR is unable to
prevent the DNA re-replication from the integrated HPV origin.
This allows us to speculate that ATR pathway does not recognize
the DNA re-replication that is initiated from the integrated HPV
origin, which might be an intrinsic property of the PV replication
machinery necessary for the amplification of the viral genome
during the initial or late phases of the viral life. The weak
localization of ATRIP and Chk1 (S317) to the sites of integrated
HPV replication as well as the poor phosphorylation of Chk1 is
not sufficient to block the replication. It is possible that the
activation of ATR is caused instead by the availability of the RPA-
coated ssDNA at the sites of fork collisions and dissociation
(Figure 9). However, if the ATR and ATRIP proteins recognize
the sites of integrated HPV replication, the possibilities to inhibit
the viral pre-RC might still be limited, since there are only few
targets in the viral replication complex that are available for ATR,
when compared with the complex initiation mechanisms of the
cellular DNA replication. Phosphorylation of the HPV E1 has
been extensively studied, but the ability of the ATR to
phosphorylate HPV E1 protein has not been demonstrated [75].
Additionally, the indirect signaling pathways of ATR through p53
and pRB could be down regulated by the HPV E6 and E7
oncoproteins. It has been also shown that the replication of BPV1
URR reporter plasmid can overcome the inhibitory effect of p53
[76]. If the prevention of DNA re-replication by ATR fails, the
accumulation of DSBs can activate the ATM pathway, as we have
concluded from our data. We observed clear localization of ATM
and Chk2 to the replication sites of the integrated HPV as well as
the clear phosphorylation of Chk2 kinase in the cell population
where the replication of the integrated HPV occurred. This
indicates that the ATM-Chk2 pathway plays the major role in
resolving the DNA damage that is caused by the replication of
integrated HPV.
Supported by the observation that Cdt1 is overexpressed in
human cancer cells, it has been suggested that DNA re-replication
can lead to the chromosomal instability and malignant transfor-
mation [71,74,77,78]. The current study provides, for the first
time, the experimental proof by metaphase FISH that DNA re-
replication can indeed lead to chromosomal instability (Figure 7).
Although we used high expression levels of the E1 in this
experiment, similar translocations of the co-localized viral-host
DNA have been detected in cell lines that were derived from
invasive genital carcinomas with native expression levels of the
viral proteins [33,58,59]. In addition, a recent study indicated that
local DNA rearrangements occur frequently and shortly after one
of the several HPV16 plasmids integrates into W12 cells [25].
The simultaneous presence of episomal and integrated HPV
DNA has been documented in HPV-infected cells, and our data
indicate that this dangerous combination can lead to the genomic
instability that is driven by the replication of the integrated HPV
origin. Such a situation can happen during the primary infection,
when one of the hundreds of HPV plasmids accidentally integrates
into the host cell genome. Loss of the episomes ultimately
generates the cells that carry only the integrated HPV DNA. Such
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the clonal progression to cancer. It is interesting to speculate
whether or not these cells can be de novo infected by homologous or
heterologous papillomaviruses. Taking into consideration that
HPV infections are frequent and wide spread, such a de novo HPV
infection could generate a similar situation with the dual status of
the HPV genome. Our data allow us to speculate that, in either
case, the unscheduled DNA re-replication at the HPV integration
locus could be induced, which would provide grounds for the
development of genomic instability leading to rearrangements and
the formation of the cancer cell. The cellular repair/recombina-
tion system is actively involved in this process and is actually the
enzymatic machinery that is responsible for introducing the
changes into the cellular genome (Figure 9).
Figure 9. Mechanism of the genomic instability of the cells harboring the replication origin of integrated HPV. If HPV plasmid is
present in the cells harboring integrated HPV, the DNA re-replication from the integrated HPV origin is initiated, and ATM and ATR signaling
pathways respond, respectively, to the produced DSBs and ssDNA. In most cases, the cells will either become apoptotic or the damage sites will be
properly repaired by homologous recombination and non-homologous end-joining. In addition, duplications within the HPV locus have previously
been detected. In the current study, the excision and generation of extrachromosomal copies of the HPV locus and cross-chromosomal translocations
were also detected. All these mutations require DSBs that could be generated, such as through head-to-tail fork collision or by encounter of the re-
replication fork with the Okazaki fragments of the previous fork. Supported by our observations, we speculate that the cellular defense against the
integrated HPV re-replication is primary coordinated by ATM. ATR pathways do not interfere with a properly working E1-driven replication fork but,
rather, are responsible for the repair of the damage that is caused by fork collision and dissociation that reveals the RPA coated ssDNA without the
generation of DSBs. DNA replication/repair factors that are shown to be within the HPV replication centers in the current work, are colored in the
figure.
doi:10.1371/journal.ppat.1000397.g009
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Plasmids
Circular HPV16 and HPV18 genomes were prepared as
described previously [60,61]. Briefly, HPV16 and HPV18
genomes were excised from the pUC or pBR vectors, respectively,
purified from the agarose gel, re-ligated, and concentrated prior to
the transfections. Plasmids pMHE1-16 and -18 and pQMNE2-16
and -18, which were used for the expression of HPV E1 and E2
proteins, respectively, were made as described previously [30].
The pauxoMCF plasmid (FitBiotech, Finland), which does not
encode any gene product in animal cells and has no significant
homology with the expression plasmids, was used in the
transfections as carrier DNA.
Antibodies
The following antibodies were used in the immunofluorescence
assays. The antibodies against BrdU (ab7384), PCNA (ab18197),
Mre11 (ab214), Rad50 (ab89), Ku70/80 (ab3108), ATM
(ab32420), ATRIP (ab19351), Chk2 (ab47433), Chk1 (ab47488)
and phospho-Chk1 (S317; ab38518) were purchased from Abcam.
The Daxx (sc7152) antibody was purchased from Santa Cruz
Biotechnology. The Nbs1 antibody (NB100-143) was purchased
from Novus Biologicals. The mouse monoclonal HA antibody
(H9658), which was used for the detection of HA-tagged HPV E1,
was purchased from Sigma-Aldrich. The polymerase a and RPA
antibodies were provided by Heinz-Peter Nashauer. A rabbit
polyclonal HA antibody was raised against the HA epitope, and a
HPV18 E2 antibody (2E7.1) was raised against a bacterially
expressed HPV18 E2 protein. Secondary antibodies that were
conjugated with Alexa Fluor 488 or Alexa Fluor 568 were
purchased from Invitrogen. Immunoprecipitations were per-
formed with mouse monoclonal antibodies that recognize human
Chk1 (c9358) and human Chk2 (c9233) (Sigma-Aldrich). Western
blotting was performed with rabbit monoclonal antibodies to Chk1
(2345), phospho-Chk1S317 (2344), Chk2 (2662), phospho-
Chk2Thr68 (2661), and phospho-Chk2Ser19 (2666) (Cell Signal-
ing Technology). Mouse monoclonal antibodies against phospho-
cH2AX-S139 (Abcam, ab18311), b-Actin (Sigma-Aldrich, A2228)
and HPV18 E2 (2E7.1) were also used. The HPV18 E1 with an
HA epitope was detected by a rat monoclonal antibody (3F10) that
was conjugated with peroxidase (Roche, 12013819001). Second-
ary antibodies conjugated with peroxidase were purchased from
LabAs Ltd (Estonia).
Cell lines and transfection
HeLa and SiHa cells were grown in Iscove’s Modified
Dulbecco’s Medium (IMDM) that was supplemented with 10%
fetal calf serum (FCS). Electroporation experiments were carried
out as described earlier [2], using the Bio-Rad Gene Pulser II
apparatus supplied with a capacitance extender (Bio-Rad
Laboratories). Capacitance was set to 975 mF and voltage to
220 V in all experiments.
1D and 2D replication analysis
Low molecular weight DNA was extracted by alkaline lysis [2]
and total DNA was extracted from cells as described previously
[79]. High-molecular-weight DNA and Low-molecular-weight
DNA were fractionated and purified by Hirt lysis [38]. Extracted
DNA was digested with the appropriate enzymes, as indicated in
Figure 1 and Figure 8. In addition, DpnI was always used to
fragmentize the input plasmids. For 1D replication analysis,
digested DNA was resolved on a 0.5–0.8% agarose gel in 16Tris-
acetate-EDTA buffer. For 2D replication analysis, the first
dimension was run on a 0.4% agarose gel in 0.56 Tris-borate-
EDTA at 0.4 V/cm for 45 h, and the second dimension was run
in 1% agarose gel on a 0.56Tris-borate-EDTA at 5.5 V/cm for
5 h at 4uC. Ethidium bromide at a concentration of 0.3 mg/ml
was added into the gel and buffer of the second dimension. The
separated DNA fragments were transferred onto a membrane and
hybridized with the appropriate
32P-labeled probes that are
specified in the legends of Figure 1 and Figure 8. In order to isolate
the supercoiled circular molecules from the replication products,
conventional CsCl density gradient centrifugation of the Hirt
LMW extract was performed according to the usual procedure
using vertical rotor VTI80 in a Beckman Coulter Optima
TM L-90
K ultracentrifuge at 50,000 rpm at 20uC for 24 h [80].
Immunofluorescence analysis
Cells were washed twice with phosphate-buffered saline (PBS),
permeabilized with 0.5% Triton X-100 in CSK buffer (10 mM
Hepes-KOH, pH 7.4; 300 mM sucrose; 100 mM NaCl; 3 mM
KCl) for 2 min on ice, and fixed with 4% paraformaldehyde.
Fixed cells were treated with 0.5% Triton X-100 in PBS, followed
by 3 PBS washes for 5 min each at RT. After blocking with 3%
bovine serum albumin (BSA) in PBS at RT for 30 min, the cells
were incubated with primary antibodies in antibody-binding
solution (3% BSA in PBS) at RT for 30 min. Cells were then
washed with 3 times with PBS for 5 min each at RT and
incubated with secondary antibodies in binding solution at RT for
30 min. Cells were washed as before, placed under coverslips with
mounting medium that contained 0.1 mM 4,6-diamidino-2-
phenylindole (DAPI), and examined with the FV1000-IX81
confocal microscope from Olympus. For BrdU labeling, the cells
were pulse-labeled for 2 h with 10 mM BrdU 18 h posttransfec-
tion. Cells were then paraformaldehyde-fixed and immunostained
for E1 (Alexa Fluor 568) as described, followed by paraformalde-
hyde-fixation, acid denaturation of the DNA, and staining with
anti-BrdU antibody conjugated with FITC (Abcam) in antibody
binding solution (3% BSA, 0.5% Triton X-100, PBS). When FISH
analysis followed IF, the cells were fixed with ice-cold methanol.
Mouse monoclonal or rabbit polyclonal HA antibody was used,
depending on the origin of the antibody to the cellular factor that
was being studied in the co-localization assay.
In situ fluorescence hybridization
To perform FISH analysis on metaphase cells, the cells were
exposed to colchicine that was added to a final concentration of
1 mg/ml for 3 h to enrich the mitotic fraction. Colchicine -treated
cells were incubated in a 1:1 mixture of 0.55% KCl and 0.95%
sodium citrate at 37uC for 10 min. The mitotic cells were then
harvested by a ‘‘shake-off’’ and incubated an additional 10 min at
37uC in the same buffer, followed by another incubation in a
0.55% KCl solution for 10 min at 37uC. Mitotic cells were fixed in
ice-cold methanol-glacial acetic acid (3:1). Spread-out chromo-
somes were prepared by dropping the cell suspension onto wet
slides, followed by quick drying on a hot metal plate. The cells
labeled by immunofluorescence were treated with ice-cold
methanol-glacial acetic acid (3:1) for 10 min, 4% paraformalde-
hyde for 10 min and a 70%, 80%, 100% ethanol series for 2 min
each. Fixed cells were treated in both cases with RNAse A
(100 mg/ml, 1 h, 37uC) and pepsin (50 mg/ml, 4 min, 37uC).
FISH hybridization probes were generated by nick translation,
using biotin-16-dUTP as a label and HPV16 genome as a
template. The final size of the probe fragments was adjusted to 200
to 500 bp by DNase I digestion. Chromosome and cell
preparations were denatured at 75uC in 70% formamide for
3 min, immediately dehydrated in a series of ethanol washes (70%,
Replication of Integrated HPV
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per slide) was composed of 50% formamide in 26 SSC, 10%
dextran sulphate, 100 ng of a denaturated probe DNA, 3 mlo f
denaturated subtelomeric probe for chromosome 13 (Cytocell
Technologies) and 5 mg of denaturated herring sperm carrier
DNA. Hybridization was performed overnight at 37uC in a moist
chamber. The following FISH procedures were performed
according to the manufacturer’s protocol (Invitrogen Corporation,
TSA
TM Kit #22). Chromosomes were counterstained with DAPI
and mounted in PBS with 50% glycerol. The slides were analyzed
with Olympus IX81 fluorescence microscope equipped with the
appropriate filter set. The chromosomes from at least 20 cells at
metaphase were analyzed on each slide.
Immunoprecipitation and western blotting
Cells on a 10 cm plate were washed twice with 16 PBS and
harvested in 0.5 ml ice-cold lysis buffer (in 50 mM Tris, pH 7.5,
150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100,
10 mM sodium fluoride, 1 mM b-glycerophosphate, 1 mM
Na3VO4, 1 mM PMSF, 1 mM DTT, and 16 complete EDTA-
free protease inhibitor mix (Roche)). Samples were sonicated on
ice three times for 5 seconds each and centrifuged for 10 min at
14,0006g, at 4uC. Two micrograms of primary antibody were
added to the supernatant, which was followed by incubation with
gentle rocking overnight at 4uC. Subsequently, 5 ml of protein G
agarose beads were added to the sample and incubated for an
additional 3 hours at 4uC. The beads were washed three times
with 1 ml of 16 cell lysis buffer and re-suspended in 16 SDS
sample buffer. The volumes of the samples were normalized
according to the initial protein concentration in the crude lysates.
The samples were heated at 100uC for 5 min and loaded onto an
SDS-PAGE gel. Thirty micrograms of total protein or 15 mlo fI P
samples were separated by electrophoresis on 10–15% polyacryl-
amide–SDS gels and transferred to Immobilon-P membrane
(Millipore, USA), with the proteins of interest detected with
antibodies described above.
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